Patent Assignment
Reel/Frame 051955/0105
Assignment of Assignor's Interest
Recorded: 2020-02-27
Pages: 4
Assignee
REVITALID, INC.
400 CROSSING BOULEVARD, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties
(4)
Compositions and Methods for Treating Blepharoptosis
Application:
62/843,819 →
Compositions and Methods for Treating Blepharoptosis
Application:
62/844,069 →
Oxymetazoline Compositions
Compositions and Methods for Treating Ocular Disorders
Patent:
10,799,481 →
Application:
16/716,014 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
May 5, 2020
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 052578/0827 →
Security Interest
May 22, 2020
From: RVL PHARMACEUTICALS, INC.
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 052734/0192 →
Security Interest
Jun 30, 2021
From: RVL PHARMACEUTICALS, INC.
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 056724/0588 →
Notice of Grant of Security Interest in Patents
Oct 12, 2021
From: RVL PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 057787/0507 →
Release of Patent Security Agreements
Oct 15, 2021
From: CIT BANK, N.A., AS COLLATERAL AGENT
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 057819/0436 →
Release of Security Interest
Oct 15, 2021
From: CIT BANK, N.A.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 057801/0484 →
Termination and Release of Security Interest in Patents Recorded at Reel 057787, Frame 0507
Nov 27, 2023
From: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 065676/0610 →
Notice of Grant of Security Interest in Patents
Nov 27, 2023
From: RVL PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 065676/0617 →